Chairman Zhong Weiping increased his stake in TAO HEUNG HLDGS (00573) by 325,000 shares at a price of approximately HK$0.3 per share.

19:36 03/04/2026

On March 30th, Chairman of the Board Zhong Weiping increased his holdings in Do Do Holdings (00573) by 325,000 shares, at a price of HK$0.2991 per share, with a total amount of approximately HK$97,200.

The latest information from the Hong Kong Stock Exchange shows that on March 30, Chairman of the Board of Directors, Chung Wai Ping, increased his holdings of TAO HEUNG HLDGS (00573) by 325,000 shares, at a price of HK $0.2991 per share, totaling approximately HK $97,200. After the increase, his latest shareholding is approximately 455 million shares, with a current shareholding ratio of 44.84%.

Roche (RHHBY.US) submitted the first non-tumor indication application for "Osimertinib Monoclonal Antibody" in China.

Astrazeneca PLC Sponsored ADR(AZN.US) launches first phase III clinical trial for its self-developed ADC drug in China.

Suzhou SLAC Precision Equipment (300382.SZ) signed a technology development contract with Beijing University of Science and Technology.

Roche (RHHBY.US) submitted the first non-tumor indication application for "Osimertinib Monoclonal Antibody" in China.

Astrazeneca PLC Sponsored ADR(AZN.US) launches first phase III clinical trial for its self-developed ADC drug in China.

Suzhou SLAC Precision Equipment (300382.SZ) signed a technology development contract with Beijing University of Science and Technology.